Crawford Fund Management’s United Therapeutics UTHR Stock Holding History

Crawford Fund Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.24M	Sell	13,368 -1,500	-10%	-$845K	1.11%	26
2026 Q1	$8.82M	Buy	14,868 +5,875	+65%	+$2.93M	1.7%	19
2025 Q4	$4.38M	Sell	8,993 -11,522	-56%	-$5.37M	0.58%	57
2025 Q3	$8.6M	Sell	20,515 -16,500	-45%	-$5.55M	1.38%	16
2025 Q2	$10.6M	Buy	37,015 +8,700	+31%	+$2.6M	1.98%	7
2025 Q1	$8.73M	Buy	28,315 +6,635	+31%	+$2.27M	2.08%	6
2024 Q4	$7.65M	Sell	21,680 -2,012	-8%	-$740K	1.33%	15
2024 Q3	$8.49M	Sell	23,692 -9,908	-29%	-$3.35M	1.82%	6
2024 Q2	$10.7M	Hold	33,600	–	–	2.7%	4
2024 Q1	$7.72M	Buy	33,600 +2,200	+7%	+$496K	1.85%	6
2023 Q4	$6.9M	Buy	+31,400	New	+$7.24M	1.37%	15

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Crawford Fund Management's UTHR Position: Q2 2026 in Review

Crawford Fund Management reduced its United Therapeutics (UTHR) stake by 10% in Q2 2026, selling an estimated $845K and leaving 13,368 shares worth $7.24M. The position accounts for 1.11% of the portfolio, ranked #26.

Crawford Fund Management first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.7M in Q2 2024. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Crawford Fund Management held 13,368 shares of United Therapeutics worth $7.24M as of Q2 2026.
Crawford Fund Management sold 1,500 United Therapeutics shares in Q2 2026, an estimated $845K.
United Therapeutics made up 1.11% of Crawford Fund Management's portfolio in Q2 2026, its #26 holding.
Crawford Fund Management first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
Crawford Fund Management's United Therapeutics position peaked at $10.7M in Q2 2024.
882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Crawford Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.